RonaldSLeuchterMD

PubMed

• 24 citations
  A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
  Sally Mortlock, Rosario I Corona, Pik Fang Kho, Paul Pharoah, Ji-Heui Seo, Matthew L Freedman, Simon A Gayther, Matthew T Siedhoff, Peter A W Rogers, Ronald Leuchter, ...> ;Cell Reports. Medicine. 2022 Mar 15
• 100 citations
  Effect of obesity on survival in epithelial ovarian cancer.
  James C. Pavelka, Rebecca S. Brown, Beth Y. Karlan, Ilana Cass, R.S. Leuchter, Leo D. Lagasse, Andrew J. Li> ;Cancer. 2006 Oct 1
• 2 citations
  Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignancies
  John C. Elkas, Jonathan S. Berek, R.S. Leuchter, Leo D. Lagasse, Beth Y. Karlan> ;Gynecologic Oncology. 2005 May 1
• 67 citations
  The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
  Andrew J. Li, Alison C Madden, Ilana Cass, R.S. Leuchter, Leo D. Lagasse, Beth Y. Karlan> ;Gynecologic Oncology. 2004 Jan 1
• 226 citations
  Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
  Robert E. Bristow, Fredrick J. Montz, Leo D. Lagasse, Ronald S. Leuchter, Beth Y. Karlan> ;Gynecologic Oncology. 1999 Mar 1
• 44 citations
  Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma
  Ohad M. Ben-Yehuda, Young B. Kim, Ronald S. Leuchter> ;Gynecologic Oncology. 1998 Jan 1
• 51 citations
  The Influence of Tumor Grade, Distribution, and Extent of Carcinomatosis in Minimal Residual Stage III Epithelial Ovarian Cancer after Optimal Primary Cytoreductive Su...
  Robin Farias-Eisner, Frances Teng, Michelle M. Oliveira, Ronald S. Leuchter, Beth Y. Karlan, Leo D. Lagasse, Jonathan S. Berek> ;Gynecologic Oncology. 1994 Oct 1
• 49 citations
  Conservative and Individualized Surgery for Early Squamous Carcinoma of the Vulva: The Treatment of Choice for Stage I and II (T1-2 N0-1 M0) Disease
  Robin Farias-Eisner, Frank D. Cirisano, Deborah Grouse, Ronald S. Leuchter, Beth Y. Karlan, Leo D. Lagasse, Jonathan S. Berek> ;Gynecologic Oncology. 1994 Apr 1
• 5 citations
  Effect of CO2 laser conization of the uterine cervix on pathologic interpretation of cervical intraepithelial neoplasia
  JM Fowler, I Davos, R.S. Leuchter, Leo D. Lagasse> ;Obstetrics and Gynecology. 1993 Jan 1
• 39 citations
  Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix
  Rolland J. Barrett, Irene Davos, Ronald S. Leuchter, Leo D. Lagasse> ;Cancer. 1987 Nov 1
• 25 citations
  Treatment of vulvar carcinoma in situ with the CO2 laser
  R.S. Leuchter, Duane E. Townsend, Neville F. Hacker, R G Pretorius, Leo D. Lagasse, Maclyn E. Wade> ;Gynecologic Oncology. 1984 Nov 1
• 29 citations
  Estrogen and progesterone receptors in ovarian neoplasms
  Larry C. Ford, Jonathan S. Berek, Leo D. Lagasse, Neville F. Hacker, Yvonne Heins, Fardad Esmailian, Ronald S. Leuchter, Robert J. DeLange> ;Gynecologic Oncology. 1983 Jun 1
• 40 citations
  Superficially invasive vulvar cancer with nodal metastases.
  Neville F. Hacker, Roberta K. Nieberg, Jonathan S. Berek, Ronald S. Leuchter, William E. Lucas, Hisham K. Tamimi, James F. Nolan, J. George Moore, Leo D. Lagasse> ;Gynecologic Oncology. 1983 Feb 1
• 7 citations
  Management of postexenteration perineal hernias by myocutaneous axial flaps
  Ronald S. Leuchter, Leo D. Lagasse, Neville F. Hacker, Jonathan S. Berek> ;Gynecologic Oncology. 1982 Aug 1
• 28 citations
  Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer
  Jonathan S. Berek, Neville F. Hacker, Leo D. Lagasse, Ronald S. Leuchter> ;Gynecologic Oncology. 1982 Feb 1
• 176 citations
  Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions.
  Neville F. Hacker, Ronald S. Leuchter, Jonathan S. Berek, Thomas W. Castaldo, Leo D. Lagasse> ;Obstetrics and Gynecology. 1981 Nov 1
• Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
  Bolton, K. L., Chenevix-Trench, G., Goh, C., Sadetzki, S., Ramus, S. J., Karlan, B. Y., Lambrechts, D., Despierre, E., Barrowdale, D., McGuffog, L., Healey, S., Easton...> ;JAMA. 2012 Jan 25
• Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
  Cass, I., Li, A. J., Runowicz, C. D., Fields, A. L., Goldberg, G. L., Leuchter, R. S., Lagasse, L. D., Karlan, B. Y.> ;Gynecol Oncol. 2001 Jan
• Splenectomy and surgical cytoreduction for ovarian cancer.
  Chen, L. M., Leuchter, R. S., Lagasse, L. D., Karlan, B. Y.> ;Gynecol Oncol. 2000 Jun
• Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
  McGonigle, K. F., Karlan, B. Y., Barbuto, D. A., Leuchter, R. S., Lagasse, L. D., Judd, H. L.> ;Gynecol Oncol. 1994 Oct
• What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995?
  Casey, A. C., Farias-Eisner, R., Pisani, A. L., Cirisano, F. D., Kim, Y. B., Muderspach, L., Futoran, R., Leuchter, R. S., Lagasse, L. D., Karlan, B. Y.> ;Gynecol Oncol. 1996 Mar
• Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
  Ioffe, Y. J., Li, A. J., Walsh, C. S., Karlan, B. Y., Leuchter, R., Forscher, C., Cass, I.> ;Gynecol Oncol. 2009 Dec 01
• A pilot study of lorazepam-induced amnesia with cis-platinum-containing chemotherapy.
  Semrad, N. F., Leuchter, R. S., Townsend, D. E., Wade, M. E., Lagasse, L. D.> ;Gynecol Oncol. 1984 Mar
• Primary carcinoma of the Bartholin gland: a report of 14 cases and review of the literature.
  Leuchter, R. S., Hacker, N. F., Voet, R. L., Berek, J. S., Townsend, D. E., Lagasse, L. D.> ;Obstet Gynecol. 1982 Sep
• Levator ani transposition for anal incompetence secondary to sphincter damage.
  Berek, J. S., Lagasse, L. D., Hacker, N. F., Leuchter, R. S.> ;Obstet Gynecol. 1982 Jan
• Join now to see all

Journal Articles

• Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cancer.  
  Cass I., Varkey T., Baldwin R.L., Moslehi R., Narod S.A., Leuchter R.S., Lagasse L.D. and Karlan B.Y., Proc AACR 1069, 42:200
• Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles.  
  Ioffe YJM, Li AJ, Walsh CS, Karlan BY, Leuchter RS, Forscher C, Cass I., Gynecol Oncol. 115(3):466-71, 12/2009
• Effect of obesity on survival in epithelial ovarian cancer.  
  Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ, Cancer 107:1520-1524, 2006
• Effect of obesity on survival in epithelial ovarian cancer.  
  Pavelka J.C., Brown R.S., Karlan B.Y., Cass I., Leuchter R.S., Lagasse L.D., Li A.J., Cancer 107:1520-1524, 2006
• Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignancies.  
  Elkas JC, Berek JS, Leuchter R, Lagasse LD, Karlan BY, Gynecol Oncol 97:685-692, 2005
• Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BYThe prognostic significance of thromboyctosis in epithelial ovarian carcinoma.  
  Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY, Gynecol Oncol 92:211-214, 2004
• Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cancer.  
  Cass I., Varkey T., Baldwin R.L., Moslehi R., Narod S.A., Leuchter R.S., Lagasse L.D. and Karlan B.Y., Gynecol Oncol 80(2):322,, 3/2002
• Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecology oncolgy  
  Cass I., Li A.J., Runowiz C.D., Fields A., Goldberg G., Lagasse L.D., Leuchter R.S., Karlan B.Y., 80 (1) 56-61, 2001
• Interstitial high-dose-rate brachytherapy using remote after loaded plyethylene tubes and a high-activity Iridim-192 source for incompletely resected gynecologic malig...  
  Casey C.A., Tassin J, Greenberg S., Palmer D, Leuchter R.S., Lagasse L.D., Karlan B.Y., Journal of Gyn Techniques 201-206, 1995
• Use of the peritoneal porta-catheter for intraperitoneal chemotherapy.  
  Schink J., Karlan B.Y., Leuchter R.S., Futoran R.J., Lagasse, L.D., Gynecologic Oncology, 1990
• Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival.  
  Berek J.S., Hacker N.F., Fu Y.S., Sokale J.R., Leuchter R.S., Lagasse L.D., Obstet Gynecol 65 : 46-52, 1985
• Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival.  
  Berek J.S., Hacker N.D., Fu Y.S., Sokale J.R., Leuchter R.S., Lagasse L.D., Obstet Gynecol 64: 837-834, 1984
• Lorazepam for chemotherapy-induced emesis. Letter to the editor.  
  Greenspoon J., Leuchter R.S., Semrad N., Arch Intern Med 144 : 2432, 1984
• Primary carcinoma Bartholin's gland: A report of 14 cases and review of the literature.  
  Leuchter R.S., Hacker N.F., Voet R.L., Berek J.S., Townsend D.E., Lagasse L.D., Obstet Gynecol 60 (3): 361, 1982
• Urologic operations as part of cytoreductive surgery for ovarian cancer.  
  Berek J.S., Hacker N.F., Leuchter R.S., Lagasse L.D., Byron R.l., Gynecol Oncol 13: 87, 1982
• Join now to see all

Books/Book Chapters

• Controversy in Obstetrics and Gynecology III 
  Chapter: Antepartum assessment of the fetus. 
  Leuchter R.S., Shifrin B.S.W.B. Saunders Company
• OB-GYN for Medical Students. 
  Chapter: Uterine corpus cancer. 
  Leuchter R.S., Wade M.EW.B. Saunders Company1994
• OB-GYN for Medical Students. 
  Chapter: Gynecologic operations 
  Leuchter R.S., Harris GW.B. Saunders Company, Philadelphia1984
• OB-GYN for Medical Students. 
  Chapter: Uterine corpus cancer. 
  Leuchter R.S., Wade M.E.W.B. Saunders Company, Philadelphia1984
• Join now to see all

Lectures

• Current Evaluation and Management of Adenocarcinoma of the Uterus 
  Grand Rounds – Cedars Sinai Medical Center
• The Role of Tumor Markers and Evaluation of Current Treatment Methods 
  Grand Rounds – Cedars Sinai Medical Center
• Oncology Nursing Seminar – An Overview on Gynecologic Oncology. 
  Cedars-Sinai Medical Center. Los Angeles, California.
• Gestational Trophoblastic Disease” 
  Kern County Ob-Gyn Conference
• DES Lecture Series – “DES Update 1981” 
  September 18, 1981 – Fresno, California
• Felmming N.....Leuchter Rl. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinom? 
  Oral presentation at the joint meeting of WAGO and SGO of Canada, Vancouver, British Columbia - 6/2009
• Ioffe Y......Leuchter R. Hormonal Therapies Demonstrate High Response Rates in Treatment of Recurrent Uterine Sarcoma. 
  Presentation at the Western Association of Gynecologic Oncologists, Sonoma, California - 6/2008
• Delic L.....Leuchter R. Brachytherapy Versus External Beam Radiation Therapy in High Intermediate Risk Endometrial Cancer Patients. 
  Presentation at the Western Association of Gynecologic Oncologists, Sonoma, California - 6/2008
• Axtell A.....Leuchter R. Oral Morbidity and mortality of early cervical cancer patients treated with radical hysterectomy followed by adjuvant radiation. 
  Presentation at the Western Association of Gynecologic Oncologists, Lake Tahoe, California - 5/2006
• Walsh C.....Leuchter R. Predictors of recurrence in endometrial cancer. 
  GlaxoSmithKline Fellows Forum - 3/2004
• Li A.....Leuchter r. Predictors of successful secondary cytoreduction in recurrent epithelial ovarian carcinoma. 
  Oral presentation at 32nd annual meeting of WAGO, Steamboat Spring, CO - 6/2003
• Cass I.....Leuchter R. Coexisting Ovarian Malignancy in Young Women with Endometrial Cancer. 
  Society of Gynecologic Oncologists, New Orleans, Louisiana - 1/2003
• Cass I..... Leuchter R. Coexisting ovarian malignancy in young women with endometrial cancer. 
  Poster presentation at SGO 34th Annual Meeting, New Orleans, Louisiana - 1/2003
• Current Concepts in Uterine Cancer and Therapeutic Lymphadenectomy. 
  OB-GYN Resident Conference - 11/1/2002
• Tiue K.....Leuchter R. Clinical Outcome of Young Women with Endometrial Carcinoma. 
  Oral Presentation at Western Association Gynecologic Oncologist Newport Beach, California - 6/12/2002
• Madden A.....Leuchter R. Prognostic Significance and Survival Impact of Second Look Surgery in Optimally Cytoreduced Advanced Stage Ovarian Cancer Patients. 
  Oral Presentation at Western Association Gynecolgic Oncologists Newport Beach, California - 6/12/2002
• Update on Surgery and Gynecologic Cancers “Current Concepts of Endometrial Cancer Screening and Treatment” “Role of Centinal Lymph Nodes in Gynecologic Oncology” “Vide... 
  Mexico OB-GYN Society, Guadalajara, Mexico. - 6/6/2002
• Madden A.....Leuchter R. Prognostic Significance and Survival Impact of Second Look Surgery in Optimally Cytoreduced Advanced Stage Ovarian Cancer Patients 
  Western Association of Gynecologic Oncologists, Newport Beach, California - 6/2002
• Clinical behavior or BRCA-associated ovarian carcinomas. 
  Oral presentation at WAGO Annual Meeting, Monterey, California - 5/2002
• Cass I.....Leuchter R. Second Look Surgery as a Prognostic Tool for Optimally Cytoreduced Ovarian Carcinoma Patients. 
  Society of Gynecologic Oncologists Miami Beach, Florida - 3/2002
• Cass I.....Leuchter R. Second look surgery as a prognostic tool for optimally cytoreduced ovarian carcinoma patients. Miami Beach, Florida, March 2002. 
  Poster presentation at Society of Gynecologic Oncologists 33rd Annual Meeting Miami Beach, Florida - 3/2002
• Li A.....Leuchter R. The prognostic significance of thrombocytosis in epithelia ovarian cancer. 
  Poster presentation at Society of Gynecologic Oncologists 33rd Annual Meeting, Miami Beach, Florida - 3/2002
• Li A......Leuchter R. The Prognostic Significance of Thrombocytosis in Epithelial Ovarian Carcinoma. 
  Western Association of Gynecologic Oncologists. Sun Valley, Idaho - 6/2001
• Li A.....Leuchter R. The prognostic significance of thrombocytosis in epithelial ovarian cancer. 
  Oral presentation at Western Association of Gynecologic Oncologists Annual Meeting, Sun Valley Idaho - 6/2001
• Cass I.....Leuchter R. Improved Chemosensitivity and Survival in BRCA1 and BRCA2 Heterozygotes with Ovarian Cancer. 
  Society Gynecologic Oncologists Nashville, Tennessee - 3/2001
• Join now to see all